Elliot works in the engineering group and has particular expertise in the automotive, bioengineering and medical device sectors. He also utilises his background in chemistry to advise on pharmaceutical and chemical composition patent applications.
Elliot works closely with all types of clients, from start-ups and Universities to large corporations, to develop a bespoke IP strategy suited to their current and future commercial needs. His day-to-day work involves leading the patent prosecution for a global supplier in the automotive sector, advising on IP strategy and FTO for biotech companies working towards IPO, and working on oppositions before the European Patent Office.
Elliot's aim is to support his clients on their business journey by working closely with them to capture and protect their IP, and develop an appropriate IP strategy to ensure that they meet their commercial goals.
Chemistry and Medicinal Chemistry
Elliot was awarded this prize from Newcastle University as part of his academic research into polymorphism of compounds and its application to intellectual property rights. In particular, his work focused on X-ray crystallographic studies of naproxen and other NSAIDs.
Elliot is the North East regional secretary of the CIPA informals, a body which represents trainee patent attorneys. As part of this role, he raises issues affecting trainees in his area, as well as organising social gatherings and sharing best practice.
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.